This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Sequenom, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Eyad Almasri: Innovator in Genetic Mosaicism Assessment
Introduction
Eyad Almasri is a notable inventor based in Escondido, California. He has made significant contributions to the field of genetic testing, particularly in the area of non-invasive prenatal testing and oncology. His innovative work has the potential to impact the way genetic conditions are assessed and classified.
Latest Patents
Eyad Almasri holds a patent for "Methods and processes for assessment of genetic mosaicism." This technology relates to the non-invasive classification of one or more mosaic copy number variations (CNVs) for a test sample. The method involves identifying a genetic copy number variation region in sample nucleic acid from a subject, determining the fraction of nucleic acid with the copy number variation, and comparing it to a fraction of minority nucleic acid, such as fetal nucleic acid. This process generates a mosaicism ratio that helps classify the presence or absence of genetic mosaicism for the copy number variation region.
Career Highlights
Eyad Almasri is currently associated with Sequenom, Inc., where he applies his expertise in genetic testing technologies. His work is instrumental in advancing non-invasive prenatal testing methods, which can provide critical information to expectant parents and healthcare providers.
Collaborations
He collaborates with notable colleagues, including Jenna L Wardrop and Ronald Michael McCullough, who contribute to the innovative environment at Sequenom, Inc. Their combined efforts enhance the research and development of genetic testing technologies.
Conclusion
Eyad Almasri's contributions to the field of genetic mosaicism assessment exemplify the impact of innovation in healthcare. His work not only advances scientific understanding but also improves the quality of prenatal testing.